Gerot Lannach
https://gl-pharma.at/home/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Gerot Lannach
Deals Shaping The Medical Industry, May 2012
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
Deals Of The Week: Allena/Althea, Almirall/Menarini, Bausch & Lomb/Ista
Earn-outs are more frequent in biotech M&A deals these days, but private investors also are becoming more savvy in terms of tracking earn-outs and which ones are more likely than others to pay off.
Valeant continues Russian spending spree with $180m Natur Produkt buy
Valeant Pharmaceuticals International Inc. saw its stock price tick up slightly after announcing its $180 million purchase of Russian over-the-counter cold remedy company Natur Produkt.
Shopaholic Valeant buys Pele and Gerot for emerging market thrust
Valeant Pharmaceuticals has announced two acquisitions in as many days, but is being a little coy as to how much it has spent.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice